Dr. Messerschmidt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
270 Curwen Rd
Bryn Mawr, PA 19010Fax+1 610-527-4857- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982
Letterman Army Medical CenterResidency, Internal Medicine, 1977 - 1979
Kaiser Permanente Northern California (San Francisco)Internship, Internal Medicine, 1976 - 1977
Oregon Health and Science University School of MedicineClass of 1976
Certifications & Licensure
TX State Medical License 1984 - 2022
PA State Medical License 2011 - 2022
CA State Medical License 2016 - 2022
IN State Medical License 2012 - 2019
FL State Medical License 1987 - 1998
MI State Medical License 1987 - 1992
MD State Medical License 1979 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy Start of enrollment: 2016 Apr 12
Publications & Presentations
PubMed
- 6 citationsCancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics.Jonathan L. Messerschmidt, Prianka Bhattacharya, Gerald L. Messerschmidt> ;Current Oncology Reports. 2017 Aug 12
- 53 citationsHow Cancers Escape Immune Destruction and Mechanisms of Action for the New Significantly Active Immune Therapies: Helping Nonimmunologists Decipher Recent AdvancesJonathan L. Messerschmidt, George C. Prendergast, Gerald L. Messerschmidt> ;The Oncologist. 2016 Feb 1
- 29 citationsExtended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D...Joseph P. Balint, Elizabeth Gabitzsch, Adrian Rice, Yvette Latchman, Younong Xu, Gerald L. Messerschmidt, Arvind Chaudhry, Michael A. Morse, Frank R. Jones> ;Cancer Immunology, Immunotherapy. 2015 May 9
- Join now to see all
Press Mentions
Immunomic Therapeutics’ VP, Clinical Development to Participate at Precision Medicine’s Webinar on Oncolytic Therapeutic DevelopmentSeptember 23rd, 2020
ACT Oncology Appoints New Chief Medical OfficerOctober 23rd, 2015
ACT Oncology Appoints New Chief Medical OfficerOctober 22nd, 2015
Hospital Affiliations
Lankenau Medical CenterWynnewood, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
